Mesoblast Limited

Mesoblast Limitedverified

MESO

Price:

$17.19

Market Cap:

$2.26B

Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells. The company's products under the Phase III clinical trials include remestemcel-L for the treatment of steroid refractory acute graft versus host disease, as well as acute respiratory distress syndrome due to COVID-19 infection; Rexle...[Read more]

Industry

Biotechnology

IPO Date

2010-01-20

Stock Exchange

NASDAQ

Ticker

MESO

The ROE as of December 2025 (TTM) for Mesoblast Limited (MESO) is -15.13%

According to Mesoblast Limited’s latest financial reports and current stock price. The company's current ROE is -15.13%. This represents a change of 482.22% compared to the average of -2.60% of the last 4 quarters.

Mesoblast Limited (MESO) Historical ROE (quarterly & annually)

How has MESO ROE performed in the past?

The mean historical ROE of Mesoblast Limited over the last ten years is -14.21%. The current -15.13% ROE has changed 6.47% with respect to the historical average. Over the past ten years (40 quarters), MESO's ROE was at its highest in in the June 2016 quarter at 9.14%. The ROE was at its lowest in in the June 2020 quarter at -5.94%.

Quarterly (TTM)
Annual

Average

-14.21%

Median

-16.66%

Minimum

-18.67%

Maximum

-0.78%

Mesoblast Limited (MESO) ROE by Quarter and Year

Discovering the peaks and valleys of Mesoblast Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.80%

Maximum Annual ROE = -0.78%

Minimum Annual Increase = -96.01%

Minimum Annual ROE = -18.67%

Quarterly (TTM)
Annual
YearROEChange
2025-17.10%-6.63%
2024-18.31%12.21%
2023-16.32%-11.21%
2022-18.38%8.14%
2021-17.00%19.78%
2020-14.19%-23.99%
2019-18.67%188.82%
2018-6.46%-56.52%
2017-14.86%1.80%
2016-0.78%-96.01%

Mesoblast Limited (MESO) Average ROE

How has MESO ROE performed in the past?

The current ROE of Mesoblast Limited (MESO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-17.24%

5-year avg

-17.42%

10-year avg

-14.21%

Mesoblast Limited (MESO) ROE vs. Peers

How is MESO’s ROE compared to its peers?

Mesoblast Limited’s ROE is greater than Ocular Therapeutix, Inc. (-87.19%), greater than Edgewise Therapeutics, Inc. (-30.65%), greater than Galapagos N.V. (-10.20%), greater than Structure Therapeutics Inc. (-21.34%), greater than uniQure N.V. (-373.73%), greater than Viridian Therapeutics, Inc. (-55.08%), greater than Liquidia Corporation (-296.78%), greater than Nuvation Bio Inc. (-54.99%), less than ImmunityBio, Inc. (64.12%), greater than Cogent Biosciences, Inc. (-120.25%),

Build a custom stock screener for Mesoblast Limited (MESO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mesoblast Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mesoblast Limited (MESO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mesoblast Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Mesoblast Limited's ROE?

How is the ROE calculated for Mesoblast Limited (MESO)?

What is the highest ROE for Mesoblast Limited (MESO)?

What is the 3-year average ROE for Mesoblast Limited (MESO)?

What is the 5-year average ROE for Mesoblast Limited (MESO)?

How does the current ROE for Mesoblast Limited (MESO) compare to its historical average?